– UK, York – Animalcare Group plc (LON: ANCR), the international animal health business, today announced the appointment of Dr. Douglas Hutchens to its Board of Directors as an Independent Non-Executive Director with immediate effect.
“We are delighted to welcome Douglas to the Animalcare Group Board. Douglas brings a wealth of expertise in veterinary medicine and R&D from leadership roles at some of the world’s biggest animal health companies. His knowledge and extensive network will prove invaluable as we pursue our long-term growth strategy.” said Board Chairman, Jan Boone.
About Dr. Douglas Hutchens
Dr. Hutchens has held several senior positions in research and development and regulatory affairs at leading global animal health companies. As part of the executive team at Bayer Animal Health, he was an EVP and Chief Veterinary Officer where he led both drug discovery and product development on a global basis. More recently, he has held positions on several R&D advisory boards.
Before joining the animal health pharmaceutical industry, Douglas was an Assistant Professor at the University of Illinois College of Veterinary Medicine. There, he conducted studies for most of the major animal health companies and participated in the development of multiple new products for companion and production animals. Early in his career, he was a practicing veterinarian. Douglas holds a Doctor of Veterinary Medicine degree and a Ph.D. in pathobiology with an emphasis in immuno-parasitology from the University of Illinois.
About Animalcare
Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organization. Animalcare operates in seven countries and exports to approximately 40 countries in Europe and worldwide. The Group is focused on bringing new and innovative products to market through its development pipeline, partnerships and via acquisition.
For more information : https://www.animalcaregroup.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
